Literature DB >> 7646446

Agonist-induced internalization and recycling of the glucagon-like peptide-1 receptor in transfected fibroblasts and in insulinomas.

C Widmann1, W Dolci, B Thorens.   

Abstract

Glucagon-like peptide-1 (GLP-1) is the most potent stimulator of glucose-induced insulin secretion and its pancreatic beta-cell receptor is a member of a new subfamily of G-protein-coupled receptors which includes the receptors for vasoactive intestinal polypeptide, secretin and glucagon. Here we studied agonist-induced GLP-1 receptor internalization in receptor-transfected Chinese hamster lung fibroblasts using three different approaches. First, iodinated GLP-1 bound at 4 degrees C to transfected cells was internalized with a t 1/2 of 2-3 min following warming up of the cells to 37 degrees C. Secondly, exposure to GLP-1 induced a shift in the distribution of the receptors from plasma membrane-enriched to endosomes-enriched membrane fractions, as assessed by Western blot detection of the receptors using specific antibodies. Thirdly, continuous exposure of GLP-1 receptor-expressing cells to iodinated GLP-1 led to a linear accumulation of peptide degradation products in the medium following a lag time of 20-30 min, indicating a continuous cycling of the receptor between the plasma membrane and endosomal compartments. Potassium depletion and hypertonicity inhibited transferrin endocytosis, a process known to occur via coated pit formation, as well as GLP-1 receptor endocytosis. In contrast to GLP-1, the antagonist exendin-(9-39) did not lead to receptor endocytosis. Surface re-expression following one round of GLP-1 receptor endocytosis occurred with a half-time of about 15 min. The difference in internalization and surface re-expression rates led to a progressive redistribution of the receptor in intracellular compartments upon continuous exposure to GLP-1. Finally, endogenous GLP-1 receptors expressed by insulinoma cells were also found to be internalized upon agonist binding. Together our data demonstrate that the GLP-1 receptor is internalized upon agonist binding by a route similar to that taken by single transmembrane segment receptors. The characterization of the pathway and kinetics of GLP-1-induced receptor endocytosis will be helpful towards understanding the role of internalization and recycling in the control of signal transduction by this receptor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7646446      PMCID: PMC1135874          DOI: 10.1042/bj3100203

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  48 in total

1.  Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors.

Authors:  M von Zastrow; B K Kobilka
Journal:  J Biol Chem       Date:  1992-02-15       Impact factor: 5.157

Review 2.  The structure and insertion of integral proteins in membranes.

Authors:  S J Singer
Journal:  Annu Rev Cell Biol       Date:  1990

Review 3.  Clathrin, adaptors, and sorting.

Authors:  B M Pearse; M S Robinson
Journal:  Annu Rev Cell Biol       Date:  1990

4.  Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization.

Authors:  S S Yu; R J Lefkowitz; W P Hausdorff
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

5.  Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Authors:  R Göke; H C Fehmann; T Linn; H Schmidt; M Krause; J Eng; B Göke
Journal:  J Biol Chem       Date:  1993-09-15       Impact factor: 5.157

6.  Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor.

Authors:  B Thorens; A Porret; L Bühler; S P Deng; P Morel; C Widmann
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

Review 7.  Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.

Authors:  B Thorens; G Waeber
Journal:  Diabetes       Date:  1993-09       Impact factor: 9.461

8.  Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.

Authors:  B Thorens
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

9.  Isoproterenol-initiated beta-adrenergic receptor diacytosis in cultured cells.

Authors:  J B Kurz; J P Perkins
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

10.  Clathrin and HA2 adaptors: effects of potassium depletion, hypertonic medium, and cytosol acidification.

Authors:  S H Hansen; K Sandvig; B van Deurs
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  49 in total

Review 1.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Comparative effects of the endogenous agonist glucagon-like peptide-1 (GLP-1)-(7-36) amide and the small-molecule ago-allosteric agent "compound 2" at the GLP-1 receptor.

Authors:  Karen Coopman; Yan Huang; Neil Johnston; Sophie J Bradley; Graeme F Wilkinson; Gary B Willars
Journal:  J Pharmacol Exp Ther       Date:  2010-05-27       Impact factor: 4.030

Review 3.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

4.  Impaired Akt activity down-modulation, caspase-3 activation, and apoptosis in cells expressing a caspase-resistant mutant of RasGAP at position 157.

Authors:  Jiang-Yan Yang; Joël Walicki; David Michod; Gilles Dubuis; Christian Widmann
Journal:  Mol Biol Cell       Date:  2005-05-18       Impact factor: 4.138

Review 5.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 6.  Glucagon-like peptide 1 (GLP-1) and metabolic diseases.

Authors:  C M Rotella; L Pala; E Mannucci
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

Review 7.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

8.  Role of the signal peptide in the synthesis and processing of the glucagon-like peptide-1 receptor.

Authors:  Y Huang; G F Wilkinson; Gary B Willars
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

9.  Fates of endocytosed somatostatin sst2 receptors and associated agonists.

Authors:  J A Koenig; R Kaur; I Dodgeon; J M Edwardson; P P Humphrey
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

10.  Interspecies modeling and prediction of human exenatide pharmacokinetics.

Authors:  Ting Chen; Donald E Mager; Leonid Kagan
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.